These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18186961)

  • 1. Different epidermal growth factor receptor gene mutations in a patient with 2 synchronous lung cancers.
    Nakano H; Soda H; Nakamura Y; Uchida K; Takasu M; Nakatomi K; Izumikawa K; Hayashi T; Nagayasu T; Tsukamoto K; Kohno S
    Clin Lung Cancer; 2007 Nov; 8(9):562-4. PubMed ID: 18186961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung.
    Kozuki T; Hisamoto A; Tabata M; Takigawa N; Kiura K; Segawa Y; Nakata M; Mandai K; Eguchi K; Ueoka H; Tanimoto M
    Lung Cancer; 2007 Oct; 58(1):30-5. PubMed ID: 17561305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal imbalances in lung adenocarcinomas with or without mutations in the epidermal growth factor receptor gene.
    Fong Y; Lin YS; Liou CP; Li CF; Tzeng CC
    Respirology; 2010 May; 15(4):700-5. PubMed ID: 20409020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas.
    Pan Q; Pao W; Ladanyi M
    J Mol Diagn; 2005 Aug; 7(3):396-403. PubMed ID: 16049312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
    Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
    Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.
    Ikeda K; Nomori H; Mori T; Sasaki J; Kobayashi T
    Ann Thorac Surg; 2008 Apr; 85(4):1430-2. PubMed ID: 18355544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.
    Haneda H; Sasaki H; Shimizu S; Endo K; Suzuki E; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Lung Cancer; 2006 Apr; 52(1):47-52. PubMed ID: 16503085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
    Takuwa T; Tanaka F; Yoneda K; Torii I; Hashimoto M; Okumura Y; Matsumoto S; Kondo N; Hasegawa S
    Lung Cancer; 2010 Jun; 68(3):498-500. PubMed ID: 20307913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
    Tam IY; Chung LP; Suen WS; Wang E; Wong MC; Ho KK; Lam WK; Chiu SW; Girard L; Minna JD; Gazdar AF; Wong MP
    Clin Cancer Res; 2006 Mar; 12(5):1647-53. PubMed ID: 16533793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
    Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
    Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.
    Kosaka T; Yatabe Y; Endoh H; Kuwano H; Takahashi T; Mitsudomi T
    Cancer Res; 2004 Dec; 64(24):8919-23. PubMed ID: 15604253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand.
    Sriuranpong V; Chantranuwat C; Huapai N; Chalermchai T; Leungtaweeboon K; Lertsanguansinchai P; Voravud N; Mutirangura A
    Cancer Lett; 2006 Aug; 239(2):292-7. PubMed ID: 16243431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor mutations in small cell lung cancer.
    Tatematsu A; Shimizu J; Murakami Y; Horio Y; Nakamura S; Hida T; Mitsudomi T; Yatabe Y
    Clin Cancer Res; 2008 Oct; 14(19):6092-6. PubMed ID: 18829487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
    Shigematsu H; Takahashi T; Nomura M; Majmudar K; Suzuki M; Lee H; Wistuba II; Fong KM; Toyooka S; Shimizu N; Fujisawa T; Minna JD; Gazdar AF
    Cancer Res; 2005 Mar; 65(5):1642-6. PubMed ID: 15753357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.
    Norkowski E; Ghigna MR; Lacroix L; Le Chevalier T; Fadel É; Dartevelle P; Dorfmuller P; Thomas de Montpréville V
    J Thorac Oncol; 2013 Oct; 8(10):1265-71. PubMed ID: 24457237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.